Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use
NCT ID: NCT00184223
Last Updated: 2016-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
135 participants
INTERVENTIONAL
2004-10-31
2005-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivational Interviewing to Reduce Substance Use Among Depression Patients
NCT02420561
Brief Intervention in Substance Use in Adolescent Psychiatric Patients
NCT00694226
The Efficacy of Brief Motivational Interviewing for Trauma Patients Related to Alcohol or Other Abuse Drugs.
NCT02159391
Three Strategies for Implementing Motivational Interviewing on Medical Inpatient Units
NCT01825057
Training Clinicians in Motivational Interviewing
NCT01065480
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Substance use and function will be followed for two years.Admittances to hospital and contacts with primary health care for five years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
motivational interviewing
Manual guided motivational interviewing in addition to treatment as usual
Motivational Interviewing
2 sessions of 45 minutes each with manual guided motivational interviewing delivered individually by a trained therapist.
Treatment as usual
Treatment as usual is individualized according to the clinical condition of the patients during the stay and in accordance with general national and international medical standards. It includes detoxification, pharmacotherapy, and general psychotherapy. Also, treatment is given for any coexisting non-substance-related disorder, including psychiatric disorders.
control group
treatment as usual
Treatment as usual
Treatment as usual is individualized according to the clinical condition of the patients during the stay and in accordance with general national and international medical standards. It includes detoxification, pharmacotherapy, and general psychotherapy. Also, treatment is given for any coexisting non-substance-related disorder, including psychiatric disorders.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational Interviewing
2 sessions of 45 minutes each with manual guided motivational interviewing delivered individually by a trained therapist.
Treatment as usual
Treatment as usual is individualized according to the clinical condition of the patients during the stay and in accordance with general national and international medical standards. It includes detoxification, pharmacotherapy, and general psychotherapy. Also, treatment is given for any coexisting non-substance-related disorder, including psychiatric disorders.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* acutely admitted to psychiatric hospital
Exclusion Criteria
* serious brain damage
* not speaking Norwegian or English
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Olavs Hospital
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gunnar Morken, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Norwegian University of Science and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Østmarka Psychiatric Department, St. Olavs Hospital, University Hospital of Trondheim
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bagoien G, Bjorngaard JH, Ostensen C, Reitan SK, Romundstad P, Morken G. The effects of motivational interviewing on patients with comorbid substance use admitted to a psychiatric emergency unit - a randomised controlled trial with two year follow-up. BMC Psychiatry. 2013 Mar 21;13:93. doi: 10.1186/1471-244X-13-93.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GB-MI-2004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.